Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329.SS)
CNY 29.42
(-6.42%)
CNY 29.42
(-6.42%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 866.66 Million | 677.24 Million | 852.4 Million | 671.42 Million | 495.48 Million | 350.14 Million |
| Net Income | 986.7 Million | 873.25 Million | 786.87 Million | 679.66 Million | 635.35 Million | 567.78 Million |
| Depreciation & Amortization | 133.15 Million | 116.55 Million | 115.53 Million | 110.84 Million | 98.14 Million | 76.14 Million |
| Deferred income taxes | -59.12 Million | -56.39 Million | 10.87 Million | 18.32 Million | -47.58 Million | -17.33 Million |
| Stock-based compensation | 18.97 Million | 6.82 Million | -10.87 Million | -18.32 Million | 47.58 Million | - |
| Change in working capital | -166.36 Million | -120.14 Million | 141.6 Million | 39.03 Million | -62.4 Million | -143.65 Million |
| Other non-cash items | 385.99 Million | -142.85 Million | -191.61 Million | -158.12 Million | -175.61 Million | -150.13 Million |
| Investing Cash Flow | -744.21 Million | -12.27 Million | -311.85 Million | 73.77 Million | -100.79 Million | 381.95 Million |
| Investments in PPE | -140.92 Million | -107.9 Million | -156.94 Million | -189.16 Million | -205.61 Million | -175.8 Million |
| Acquisitions | 3.06 Million | -47.61 Million | 28.71 Million | 195.93 Million | 243.96 Million | - |
| Investment purchases | -656 Million | -530 Million | -349.92 Million | -34.47 Billion | -71.55 Billion | -38.66 Billion |
| Sales/Maturities of investments | 49.64 Million | 671.74 Million | 166.3 Million | 34.73 Billion | 71.61 Billion | 39.23 Billion |
| Other Investing Activities | -427.98 Million | 1.48 Million | 1.06 | -189.16 Million | -205.61 Million | -10.05 Million |
| Financing Cash Flow | -836.64 Million | -236.61 Million | -244.7 Million | -237.26 Million | -370.36 Million | -252.14 Million |
| Debt repayment | -69.89 Million | -24.17 Million | -1.42 Million | -1.1 Million | -352 Million | -382 Million |
| Dividends payments | -859.14 Million | -386.72 Million | -231.97 Million | -231.81 Million | -169.15 Million | -164.74 Million |
| Common Stock Repurchased | -22.66 Million | - | -1.35 Million | -696.66 Thousand | -28.29 Million | - |
| Common Stock Issuance | - | - | 2.77 Million | 1.8 Million | 28.29 Million | - |
| Other Financing Activities | -21.49 Million | 174.98 Million | -12.64 Million | -4.65 Million | 154.99 Million | 294.6 Million |
| Accounts receivables | 74 Million | -732.29 Million | -42.06 Million | -113.8 Million | -102.7 Million | -160.83 Million |
| Accounts payables | -56.05 Million | 609.67 Million | 220.2 Million | 23.55 Million | 380.44 Million | 274.5 Million |
| Inventory | -165.33 Million | 58.87 Million | -47.4 Million | 110.95 Million | -292.56 Million | -239.99 Million |
| Other working capital | -18.97 Million | -56.39 Million | 10.87 Million | 18.32 Million | -47.58 Million | 96.34 Million |
| Cash at beginning of period | 2.88 Billion | 2.28 Billion | 1.98 Billion | 1.47 Billion | 1.45 Billion | 975.11 Million |
| Cash at end of period | 2.12 Billion | 2.71 Billion | 2.28 Billion | 1.98 Billion | 1.47 Billion | 1.45 Billion |
| Capital Expenditure | -140.92 Million | -107.9 Million | -156.94 Million | -189.16 Million | -205.61 Million | -175.8 Million |
| Effect of forex changes on cash | 45.34 Thousand | 5975.36 | 0.22 | 0.17 | 0.38 | - |
| Net cash flow / Change in cash | -757.32 Million | 428.35 Million | 295.84 Million | 507.93 Million | 24.33 Million | 479.95 Million |
| Free Cash Flow | 725.74 Million | 569.34 Million | 695.45 Million | 482.25 Million | 289.87 Million | 174.33 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 146.13 Million | 270.39 Million | 387.32 Million | 986.7 Million | 128.51 Million | 135.7 Million |
| Depreciation & Amortization | - | 31.55 Million | 31.55 Million | 133.15 Million | 34.03 Million | -62.6 Million |
| Deferred income taxes | - | - | - | -59.12 Million | - | -319.09 Million |
| Stock-based compensation | - | 174.78 Thousand | - | 18.97 Million | 18.97 Million | -19.7 Million |
| Change in working capital | - | -151.22 Million | - | -166.36 Million | -110.31 Million | 331.3 Million |
| Other non-cash items | -130.14 Million | 407.36 Million | -306.01 Million | 385.99 Million | 444.75 Million | -106.85 Million |
| Investing Cash Flow | -1.24 Billion | -53.06 Million | -54.17 Million | -744.21 Million | -83.27 Million | 1.54 Million |
| Investments in PPE | -42.46 Million | -23.11 Million | -14.19 Million | -140.92 Million | -57.27 Million | -18.54 Million |
| Acquisitions | - | 53.19 Thousand | 25.88 Thousand | 3.06 Million | -100.44 | 2.88 Million |
| Investment purchases | -1.2 Billion | -70 Million | -40 Million | -656 Million | -26 Million | -50 Million |
| Sales/Maturities of investments | 3.6 Million | 40 Million | 170.61 Million | 49.64 Million | - | 70.09 Million |
| Other Investing Activities | - | 51.19 Million | 130.64 Million | -427.98 Million | -0.56 | -2.88 Million |
| Financing Cash Flow | -751.41 Million | 425.45 Million | 294.43 Million | -836.64 Million | -456.26 Million | -33.07 Million |
| Debt repayment | -221.09 Million | -434.99 Million | -300 Million | -69.89 Million | -448.77 Million | -177.89 Million |
| Dividends payments | -971.98 Million | -8.95 Million | -2.22 Million | -859.14 Million | -859.14 Million | -4.66 Million |
| Common Stock Repurchased | - | - | - | -22.66 Million | -22.66 Million | 22.15 Million |
| Common Stock Issuance | - | - | - | - | - | 180.86 Thousand |
| Other Financing Activities | -529.8 Thousand | -8.42 Million | -5.56 Million | -21.49 Million | 877.56 Million | 127.14 Million |
| Accounts receivables | - | -151.71 Million | - | 74 Million | 74 Million | 76.89 Million |
| Accounts payables | - | - | - | -56.05 Million | - | - |
| Inventory | - | 499.01 Thousand | - | -165.33 Million | -165.33 Million | 254.4 Million |
| Other working capital | - | - | - | -18.97 Million | -18.97 Million | - |
| Cash at beginning of period | 3.33 Billion | 2.45 Billion | 2.12 Billion | 2.88 Billion | 2.01 Billion | 2 Billion |
| Cash at end of period | 1.35 Billion | 3.45 Billion | 2.45 Billion | 2.12 Billion | 2.12 Billion | 1.92 Billion |
| Capital Expenditure | -42.46 Million | -23.11 Million | -14.19 Million | -140.92 Million | -57.27 Million | -18.54 Million |
| Effect of forex changes on cash | -44.14 Thousand | -12.27 Thousand | -55.93 Thousand | 45.34 Thousand | 860.9 Thousand | 6357.28 |
| Net cash flow / Change in cash | -1.97 Billion | 996.51 Million | 332.41 Million | -757.32 Million | 105.3 Million | -72.76 Million |
| Free Cash Flow | -26.47 Million | 623.09 Million | 67.11 Million | 725.74 Million | 550.02 Million | -59.79 Million |
KRDXF
ALEMG
5243
SGRP
STEV
7161